STEPHEN SCHAFFER
Allopathic & Osteopathic Physicians|Otolaryngology ANCHORAGE, AK NPI 1720051089
Browse related groups: Allopathic & Osteopathic Physicians|Otolaryngology AK GENZYME CORPORATION All categories
General Payments — all program years on this page
$1,697.75
- Category: General Payments
- Program years: PY2018–2024
- Record count: 37
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $278.96 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $278.96 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $132.96 | 3 |
| GlaxoSmithKline, LLC. | $44.74 | 2 |
| Integra LifeSciences Corporation | $39.83 | 1 |
| Smith & Nephew, Inc. | $30.86 | 1 |
| Regeneron Healthcare Solutions, Inc. | $30.57 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1114159352 | Regeneron Healthcare Solutions, Inc. | $30.57 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116253983 | GlaxoSmithKline, LLC. | $20.08 | 03/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116537614 | GlaxoSmithKline, LLC. | $24.66 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139660112 | GENZYME CORPORATION | $6.25 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139660148 | GENZYME CORPORATION | $18.38 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139660162 | GENZYME CORPORATION | $108.33 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1140135541 | Integra LifeSciences Corporation | $39.83 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1149576938 | Smith+Nephew, Inc. | $30.86 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.